MannKind and One Drop hope to prove the inhaled insulin Afrezza works better for patients when paired with a digital management diabetes system.
Not every baseball fan wants peanuts and Cracker Jack—especially fans with severe allergies. But Kaléo has a solution.
Tesaro’s PARP contender Zejula has only been around since April, but that’s all the time it needed to snag the No. 1 position in the space.
It wasn’t long ago that Lundbeck was struggling. But thanks to some new launches, the company is poised to post its best-ever financial year.
Amgen debuted a Prolia TV ad with longtime spokesperson Blythe Danner, just weeks after a setback for its next-gen osteoporosis med romosozumab.
Bristol-Myers Squibb will soon bid farewell to exclusivity on a pair of HIV drugs—and, as a result, 58 workers will bid farewell to their jobs.
It's an ongoing claim that no one wants to see pharma ads. But you can't argue with data, and people aren't clicking away when the TV ads pop up.
Allergan’s new rosacea treatment Rhofade is gaining insurance coverage—and that means more promotion is on the way.
In Amgen’s latest campaign for Enbrel, kids are speaking up. Two new commercials feature children talking about their parents’ arthritis.
Pfizer's Ibrance just wrapped its first full quarter of fighting new in-class rival Kisqali, but the juggernaut shows no sign of slowing down.